In a large series of 713 consecutive hormone receptor-negative invasive BC, Liu et al. [17] reported 8% of basal-HER2+ cases expressing HER2 and any of the basal markers CK5/6, CK14, or EGFR. The gene discussed is EGFR; the disease is breast cancer.